Skip to content
Stocks News
Enter Ticker Symbol
  • Home
  • FEATURED COMPANY
  • ANALYST COVERAGE
  • NEWS
  • SUBSCRIBE
  • CONTACT

ANALYST COVERAGE

bofa-reiterates-buy-on-ibm,-international-business-machines-corporation-mar-2026

BofA Reiterates Buy on IBM, International Business Machines Corporation Mar 2026

Mar 11, 2026

Bank of America Securities reiterated a Buy on IBM (International Business Machines Corporation) on March 10, 2026 at…

Read more
cowen-maintains-buy-on-protara-therapeutics-(tara)-march-10,-2026

Cowen Maintains Buy on Protara Therapeutics (TARA) March 10, 2026

Mar 11, 2026

Cowen & Co. maintained its Buy rating on Protara Therapeutics, Inc. (TARA) on March 10, 2026 after an…

Read more
hc-wainwright-maintains-buy-on-capricor-therapeutics,-inc.-(capr)-mar-2026

H.C. Wainwright Maintains Buy on Capricor Therapeutics, Inc. (CAPR) Mar 2026

Mar 11, 2026

On March 10, 2026 H.C. Wainwright maintained a Buy on Capricor Therapeutics, Inc. (CAPR), a clear signal for…

Read more
ubs-maintains-neutral-on-hewlett-packard-enterprise-company-(hpe)-march-2026

UBS Maintains Neutral on Hewlett Packard Enterprise Company (HPE) March 2026

Mar 11, 2026

UBS maintained a Neutral rating on Hewlett Packard Enterprise Company on March 10, 2026, the most important published…

Read more
leerink,-needham-maintain-outperform-and-buy-on-medtronic-plc-(mdt)-mar-2026

Leerink, Needham Maintain Outperform and Buy on Medtronic plc (MDT) Mar 2026

Mar 11, 2026

On March 10, 2026, Leerink maintained an Outperform and Needham maintained a Buy on Medtronic plc (MDT). Our…

Read more
leerink-maintains-market-perform-on-zoetis-inc.-(zts)-march-10,-2026

Leerink Maintains Market Perform on Zoetis Inc. (ZTS) March 10, 2026

Mar 11, 2026

Leerink Partners on March 10, 2026 maintained a Market Perform rating on Zoetis Inc. (ZTS). The ZTS analyst…

Read more
morgan-stanley-maintains-overweight-buy-on-biontech-se-(bntx)-march-10,-2026

Morgan Stanley Maintains Overweight Buy on BioNTech SE (BNTX) March 10, 2026

Mar 10, 2026

Morgan Stanley on March 10, 2026 maintained its Overweight and Buy calls on BioNTech SE (BNTX), keeping pressure…

Read more
sentinelone-(s)-valuation-check-as-new-coverage-identity-platform-and-cfo-transition-draw-attention

SentinelOne (S) Valuation Check As New Coverage Identity Platform And CFO Transition Draw Attention

Mar 10, 2026

SentinelOne (S) is back in focus after a busy few weeks that combined fresh analyst coverage, a new…

Read more
this-strategy-analyst-begins-coverage-on-a-bullish-note;-here-are-top-5-initiations-for-tuesday

This Strategy Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

Mar 10, 2026

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst…

Read more
a-look-at-cava-group’s-(cava)-valuation-after-fresh-analyst-coverage-and-growing-growth-optimism

A Look At CAVA Group’s (CAVA) Valuation After Fresh Analyst Coverage And Growing Growth Optimism

Mar 10, 2026

CAVA Group (CAVA) has been back in focus after fresh analyst coverage highlighted its role in Mediterranean fast…

Read more
raymond-james-names-aqnu-(algonquin-power-&-utilities-corp.)-outperform-mar-2026

Raymond James names AQNU (Algonquin Power & Utilities Corp.) Outperform Mar 2026

Mar 10, 2026

Raymond James upgraded Algonquin Power & Utilities Corp. (AQNU) to Outperform on Mar 9, 2026, a clear AQNU…

Read more
wall-street-lifts-targets-on-five-below,-ulta-beauty-and-nature’s-sunshine-ahead-of-key-earnings-reports

Wall Street Lifts Targets on Five Below, Ulta Beauty and Nature’s Sunshine Ahead of Key Earnings Reports

Mar 10, 2026

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions…

Read more
  1. Pages:
  2. «
  3. 1
  4. ...
  5. 10
  6. 11
  7. 12
  8. 13
  9. 14
  10. 15
  11. 16
  12. ...
  13. 377
  14. »

Posts pagination

Newer posts Page 1 … Page 13 … Page 377 Older posts

The content presented on this site is intended solely for entertainment purposes and should not be construed as an invitation to engage in the purchase or sale of securities. Each content provider featured on 10x Wealth Report brings a unique perspective and predisposition, which may not necessarily align with that of 10x Wealth Report. It is crucial to recognize that 10x Wealth Report is not a registered financial advisor or firm. Read More full disclaimer

CATEGORIES

  • FEATURED COMPANY
  • NEWS
  • ANALYST COVERAGE
  • Special Post
  • CONTACT
  • SUBSCRIBE
  • Privacy Policy
  • Terms or Service
  • Disclaimer

CONNECT & FOLLOW

© 10x Wealth Report Copyright 2024.